A clinical company building the part of recovery
nobody does.
We are building a DiGA designed around the addiction therapy waitlist — a population no other listed product treats as its primary user. We work with the institutions that set the standard, and hold ourselves to the same bar.
Working with the institutions
that set the German standard.
Our collaborators span academic psychiatry, affective science, digital health methodology, and regulatory affairs. We will name them when the formal partnerships are in place.
Three commitments
that decide every product call.
Affect labeling. Urge surfing. Cognitive restructuring. Problem-solving. Social action. Each module is grounded in published evidence with effect sizes we can name.
A state machine controls flow. The LLM is a delivery interface, not a clinical reasoning engine. Every output passes regex, keyword, and semantic safety checks.
A controlled validation study against the current standard of care for the addiction therapy waitlist — which is nothing. Primary endpoint: depression and anxiety. Secondary: percent days abstinent.
Designed as Class I under MDR.
Self-certifiable. By design.
Fixed-schedule psychoeducation and self-help skills — identical content for all users in the same week. No adaptive clinical logic, so the Class I self-certification path is open to us with no Notified Body required. CE marking and the BfArM DiGA listing are work in progress; neither is in place today.
Pre-CE · Pre-DiGA listing